Suchergebnisse - "Mecheri, Valentina"

PubPharm (10)

1

"Patient remodeling" as a consequence of uncontrolled and prolonged OCS use in severe asthma : how biologic therapy can reverse a dangerous trend

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2024

von Perlato, M. | Mecheri, V. | Vivarelli, E. | +3

2

Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab

enthalten in: Allergy | 2023

von Vultaggio, A. | Accinno, M. | Vivarelli, E. | +8

3

Desensitization Protocol for Cemiplimab-Related Infusion Reaction in Cutaneous Squamous Cell Carcinoma : A Case Report and Literature Review

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Banini, M. | Salvestrini, V. | Vultaggio, A. | +8

4

EGPA Phenotyping : Not Only ANCA, but Also Eosinophils

enthalten in: Biomedicines | 2023

von Matucci, A. | Vivarelli, E. | Perlato, M. | +6

5

Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis

enthalten in: The Journal of allergy and clinical immunology | 2023

von Sordi, B. | Vanderwert, F. | Crupi, F. | +26

6

High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2023

von Matucci, A. | Nencini, F. | Maggiore, G. | +14

7

Rituximab and infliximab desensitization with anti-IgE mAb omalizumab as adjuvant therapy : a case series

enthalten in: The journal of allergy and clinical immunology. In practice | 2022

von Perlato, M. | Mecheri, V. | Accinno, M. | +3

8

Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA : A Real-Life Experience

enthalten in: Biomedicines | 2022

von Matucci, A. | Vivarelli, E. | Perlato, M. | +6

9

Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome : A Case Report With Leishmaniasis and Review of the Literature

enthalten in: Frontiers in immunology | 2022

von Palterer, B. | Salvati, L. | Capone, M. | +15

10

The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer

enthalten in: Gynecologic oncology reports | 2021

von Vultaggio, A. | Petrella, M. | Tomao, F. | +10

1
[1]